Investigations of botanicals on food intake, satiety, weight loss and oxidative stress: Study protocol of a double-blind, placebo-controlled, crossover study

Journal of Chinese Integrative Medicine

Volumn 9, Issue 11, 2011, Pages 1190-1198

  Anton, Stephen D ^a   Shuster, Jonathan ^a   Leeuwenburgh, Christiaan ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Anti obesity agents; Clinical protocols; Crossover study; Dietary supplements; Garcinia cambogia; Hydroxycitric acid; Plant extracts

Indexed keywords

HYDROXYCITRIC ACID; PLACEBO;

ADULT; AGED; BODY WEIGHT; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FOOD INTAKE; GARCINIA CAMBOGIA; HUMAN; MEAL; OBESITY; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SATIETY; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

AGED; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; EATING; HUMANS; MIDDLE AGED; OVERWEIGHT; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SATIATION; WEIGHT LOSS;

EID: 81155123254     PISSN: 16721977     EISSN: None     Source Type: Journal    
DOI: 10.3736/jcim20111106     Document Type: Review

References (45)

1. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. N Engl J Med. 2002; 347(5): 305-313.
2. Key TJ, Allen NE, Spencer EA, Travis RC. The effect of diet on risk of cancer. Lancet. 2002; 360 (9336): 861-868.
3. Roth J, Qiang X, Marban SL, Redelt H, Lowell BC. The obesity pandemic: where have we been and where are we going? Obes Res. 2004; 12 (Suppl 2): 88S-101S.
4. Das M, Gabriely I, Barzilai N. Caloric restriction, body fat and ageing in experimental models. Obes Rev. 2004; 5(1): 13-19.
5. Kloting N, Bliiher M. Extended longevity and insulin signaling in adipose tissue. Exp Gerontol. 2005; 40 (11): 878-883.
6. Roth GS, Ingram DK, Joseph JA. Nutritional interventions in aging and age-associated diseases. Ann N Y Acad Sci. 2007; 1114: 369-371.
7. Bodkin NL, Alexander TM, Ortmeyer HK, Johnson E, Hansen BC. Mortality and morbidity in laboratory-maintained Rhesus monkeys and effects of long-term dietary restriction. J Gerontol A Biol Sci Med Sci. 2003; 58(3): 212-219.
8. Kayo T, Allison DB, Weindruch R, Prolla TA. Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys. Proc Natl Acad Sci U S A. 2001; 98(9): 5093-5098.
9. Heilbronn LK, de Jonge L, Frisard MI, DeLany JP, Larson-Meyer DE, Rood J, Nguyen T, Martin CK, Volaufova J, Most MM, Greenway FL, Smith SR, Deutsch WA, Williamson DA, Ravussin E; Pennington CALERIE Team. Effect of 6-month calorie restriction on biomarkers of longevity, metabolic adaptation, and oxidative stress in overweight individuals: a randomized controlled trial. JAMA. 2006; 295(13): 1539-1548.
10. Goldstein DJ. Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992; 16(6): 397-415.
11. Scheen AJ. The future of obesity: new drugs versus lifestyle interventions. Expert Opin Investig Drugs. 2008; 17 (3): 263-267.
12. McGuire MT, Wing RR, Klem ML, Lang W, Hill JO. What predicts weight regain in a group of successful weight losers? J Consult Clin Psychol. 1999; 67(2): 177-185.
13. MacLean PS, Higgins JA, Jackman MR, Johnson GC, Fleming-Elder BK, Wyatt HR, Melanson EL, Hill JO. Peripheral metabolic responses to prolonged weight reduction that promote rapid, efficient regain in obesity-prone rats. Am J Physiol Regul Integr Comp Physiol. 2006; 290(6): R1577-R1588.
14. Blanck HM, Khan LK, Serdula MK. Use of nonprescription weight loss products: results from a multistate survey. JAMA. 2001; 286(8): 930-935.
15. Goldman EL. Industry self-regulation in the manufacture of dietary supplements and botanical medicines. Clin Obstet Gynecol. 2001; 44(4): 789-800.
16. Pittler MH, Ernst E. Complementary therapies for reducing body weight: a systematic review. Int J Obes (Lond). 2005; 29(9): 1030-1038.
17. Bray GA. Are non-prescription medications needed for weight control? Obesity (Silver Spring). 2008; 16(3): 509-514.
18. Clouatre D, Talpur N, Talpur F, Echard B, Preuss H. Comparing metabolic and inflammatory parameters among rats consuming different forms of hydroxycitrate. The American College of Nutrition 46th Annual Meeting, Kiawah Island, South Carolina, September 22-25, 2005.
19. Clouatre DL, Preuss HG. Potassium magnesium hydroxycitrate at physiologic levels influences various metabolic parameters and inflammation in rats. Curr Top Nutraceutical Res. 2008; 6(4): 201-210.
20. Greenwood MR, Cleary MP, Gruen R, Blase D, Stern JS, Triscari J, Sullivan AC. Effect of (-)-hydroxycitrate on development of obesity in the Zucker obese rat. Am J Physiol. 1981; 240(1): E72-E78.
21. Leonhardt M, Hrupka B, Langhans W. Effect of hydroxycitrate on food intake and body weight regain after a period of restrictive feeding in male rats. Physiol Behav. 2001; 74(1-2): 191-196.
22. Asghar M, Monjok E, Kouamou G, Ohia SE, Bagchi D, Lokhandwala MF. Super CitriMax (HCA-SX) attenuates increases in oxidative stress, inflammation, insulin resistance, and body weight in developing obese Zucker rats. Mol Cell Biochem. 2007; 304(1-2): 93-99
23. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998; 280(18): 1596-1600.
24. Westerterp-Plantenga MS, Kovacs EM. The effect of (-)-hydroxycitrate on energy intake and satiety in overweight humans. Int J Obes Relat Metab Disord. 2002; 26(6): 870-872.
25. Sullivan AC, Hamilton JG, Miller ON, Wheatley VR. Inhibition of lipogenesis in rat liver by (-)-hydroxycitrate. Arch Biochem Biophys. 1972; 150(1): 183-190.
26. McCarty MF. Promotion of hepatic lipid oxidation and gluconeogenesis as a strategy for appetite control. Med Hypotheses. 1994; 42(4): 215-225.
27. Roy S, Shah H, Rink C, Khanna S, Bagchi D, Bagchi M, Sen CK. Transcriptome of primary adipocytes from obese women in response to a novel hydroxycitric acid-based dietary supplement. DNA Cell Biol. 2007; 26 (9): 627-639.
28. Shara M, Ohia SE, Yasmin T, Zardetto-Smith A, Kincaid A, Bagchi M, Chatterjee A, Bagchi D, Stohs SJ. Dose- and time-dependent effects of a novel (-)-hydroxycitric acid extract on body weight, hepatic and testicular lipid peroxidation, DNA fragmentation and histopathological data over a period of 90 days. Mol Cell Biochem. 2003; 254(1-2): 339-346.
29. Anton SD, Morrison CD, Cefalu WT, Martin CK, Coulon S, Geiselman P, Han H, White CL, Williamson DA. Effects of chromium picolinate on food intake and satiety. Diabetes Technol Ther. 2008; 10(5): 405-412.
30. Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio: Psychological Corporation. 1996.
31. Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res. 1985; 29(1): 71-83.
32. Stice E, Telch CF, Rizvi SL. Development and validation of the Eating Disorder Diagnostic Scale: a brief self-report measure of anorexia, bulimia, and binge-eating disorder. Psychol Assess. 2000; 12(2): 123-131.
33. Stice E, Fisher M, Martinez E. Eating disorder diagnostic scale: additional evidence of reliability and validity. Psychol Assess. 2004; 16(1): 60-71.
34. Kissileff HR, Klingsberg G, Van Itallie TB. Universal eating monitor for continuous recording of solid or liquid consumption in man. Am J Physiol. 1980; 238 (1): R14-R22.
35. Kissileff HR, Thornton J, Becker E. A quadratic equation adequately describes the cumulative food intake curve in man. Appetite. 1982; 3(3): 255-272.
36. Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes Relat Metab Disord. 2000; 24(1): 38-48.
37. White MA, Whisenhunt BL, Williamson DA, Greenway FL, Netemeyer RG. Development and validation of the food-craving inventory. Obes Res. 2002; 10(2): 107114.
38. Hofer T, Seo AY, Prudencio M, Leeuwenburgh C. A method to determine RNA and DNA oxidation simultaneously by HPLC-ECD: greater RNA than DNA oxidation in rat liver after doxorubicin administration. Biol Chem. 2006; 387(1): 103-111.
39. Shuster JJ. Design of experiments. In, Ambrosius WT. Methods in molecular biology: elementary biosta-tistics. Totawa: Humana Press. 2007: 235-260.
40. Hayamizu K, Ishii Y, Kaneko I, Shen M, Okuhara Y, Sakaguchi H, Shigematsu N, Shimasaki H. No-observed-adverse-effect level (NOAEL) and sequential-high doses administration study on Garcinia cambogia extract in humans. J Oleo Sci. 2002; 51 (5): 365-369. Japanese with abstract in English.
41. Adam TC, Westerterp-Plantenga MS. Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects. Br J Nutr. 2005; 93 (6): 845-851.
42. Keim NL, Stern JS, Havel PJ. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am J Clin Nutr. 1998; 68(4): 794-801.
43. Rosenbaum M, Nicolson M, HirschJ, Murphy E, Chu F, Leibel RL. Effects of weight change on plasma leptin concentrations and energy expenditure. J Clin Endocrinol Metab. 1997; 82(11): 3647-3654.
44. Levin BE. The drive to regain is mainly in the brain. Am J Physiol Regul Integr Comp Physiol. 2004; 287 (6): R1297-R1300.
45. Levine JA. Nonexercise activity thermogenesis (NEAT): environment and biology. Am J Physiol Endocrinol Metab. 2004; 286(5): E675-E685.